» Articles » PMID: 8697297

A Minimal Model Using Stable Isotopes to Study the Metabolism of Apolipoprotein B-containing Lipoproteins in Humans

Overview
Journal Diabetes Metab
Specialty Endocrinology
Date 1996 Feb 1
PMID 8697297
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

A protocol using stable isotopes, developed to measure apolipoprotein B turnover in humans, was tested by intravenous infusion of [2H3]-leucine into 5 normolipidemic volunteers during a 14-h fast. Tracer-to-tracee ratio curves were analyzed by four different approaches: linear regression, monoexponential regression, a minimal compartmental model (3 compartments) and a complex model (4 compartments and two shunt pathways). The three-compartment model was validated by qualitative analysis of data obtained after injection of a [2H3]-leucine bolus. This simple model gave an FCR of 0.48 +/- 0.05 h-1 for VLDL, 0.62 +/- 0.08 h-1 for IDL and 0.022 +/- 0.002 h-1 for LDL. The total production rate of apolipoprotein B in plasma was 24.8 +/- 6.5 mg.kg-1.day-1. Kinetic parameters were similar for the complex model which showed no improvement in fit. Lower estimates were observed with the non-compartmental approaches.

Citing Articles

Link between Omega 3 Fatty Acids Carried by Lipoproteins and Breast Cancer Severity.

Bobin-Dubigeon C, Nazih H, Croyal M, Bard J Nutrients. 2022; 14(12).

PMID: 35745191 PMC: 9230874. DOI: 10.3390/nu14122461.


Effect of fasting and feeding on apolipoprotein A-I kinetics in preβ-HDL, α-HDL, and triglyceride-rich lipoproteins.

Chetiveaux M, Croyal M, Ouguerram K, Fall F, Flet L, Zair Y Sci Rep. 2020; 10(1):15585.

PMID: 32973209 PMC: 7519065. DOI: 10.1038/s41598-020-72323-w.


Multiplexed peptide analysis for kinetic measurements of major human apolipoproteins by LC/MS/MS.

Croyal M, Fall F, Ferchaud-Roucher V, Chetiveaux M, Zair Y, Ouguerram K J Lipid Res. 2016; 57(3):509-15.

PMID: 26773160 PMC: 4766983. DOI: 10.1194/jlr.D064618.


Analysis of "On/Off" Kinetics of a CETP Inhibitor Using a Mechanistic Model of Lipoprotein Metabolism and Kinetics.

Lu J, Cleary Y, Maugeais C, Kiu Weber C, Mazer N CPT Pharmacometrics Syst Pharmacol. 2015; 4(8):465-73.

PMID: 26380155 PMC: 4562162. DOI: 10.1002/psp4.27.


Effects of 20 mg rosuvastatin on VLDL1-, VLDL2-, IDL- and LDL-ApoB kinetics in type 2 diabetes.

Verges B, Florentin E, Baillot-Rudoni S, Monier S, Petit J, Rageot D Diabetologia. 2008; 51(8):1382-90.

PMID: 18535816 DOI: 10.1007/s00125-008-1046-4.